LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +5 | 56.58M | $15.83B | +9 | −3 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | — | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | — |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | — | 5.93M | $1.21B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 1.95M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 1.95M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (pasif) | 1.03M | — | $209.67M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 207.51K | — | $42.23M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 117.05K | — | $23.82M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 117.05K | — | $23.82M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 71.08K | — | $14.47M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 71.08K | — | $14.47M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 20.90K | — | $4.25M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 19.93K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 1.50K | — | $305,265 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 1.25K | — | $253,908 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,014 pemegang, 76.41M saham, $19.36B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 3.00K lbr · $954,060
Officer, Director · 4.67K lbr · $1.50M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi